Back
DoubleLine Yield Opportunities Fund Vs. AnaptysBio, Inc. Industry Stock Comparison
Sell
31
DLY
DoubleLine Yield Opportunities Fund
Last Price:
$13.76
Seasonality Move:
-1.08%
Sell
47
ANAB
AnaptysBio, Inc.
Last Price:
$57.92
Seasonality Move:
5.3%
Sell
31
DoubleLine Yield Opportunities Fund (DLY)
is a Sell
Is DoubleLine Yield Opportunities Fund a Buy, Sell or Hold?
-
The current DoubleLine Yield Opportunities Fund [DLY] share price is $13.74. The Score for DLY is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
-
DLY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
AnaptysBio, Inc. (ANAB)
is a Sell
Is AnaptysBio, Inc. a Buy, Sell or Hold?
-
The current AnaptysBio, Inc. [ANAB] share price is $57.68. The Score for ANAB is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ANAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DLY Stock Price Chart
What is DoubleLine Yield Opportunities Fund's stock price today?
-
The DoubleLine Yield Opportunities Fund share price today is $13.74Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DLY is experiencing slight selling pressure.
ANAB Stock Price Chart
What is AnaptysBio, Inc.'s stock price today?
-
The AnaptysBio, Inc. share price today is $57.68The current trend is relatively stagnant and ANAB is experiencing slight selling pressure.
DLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.21 | Sell |
| Relative Strength Index (14 RSI): | 40.33 | Sell |
| Chaikin Money Flow: | -78879 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.69 - 14.37) | Sell |
| Bollinger Bands (100): | (14.17 - 14.87) | Sell |
ANAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 46.79 | Sell |
| Chaikin Money Flow: | -120538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.32 - 64.78) | Sell |
| Bollinger Bands (100): | (41.49 - 58.03) | Buy |
DLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.73 | Buy |
| 20-day SMA: | 13.9 | Sell |
| 50-day SMA: | 14.42 | Sell |
| 200-day SMA: | 14.89 | Sell |
| 8-day EMA: | 13.77 | Sell |
| 20-day EMA: | 13.93 | Sell |
| 50-day EMA: | 14.25 | Sell |
| 200-day EMA: | 14.81 | Sell |
ANAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.51 | Sell |
| 20-day SMA: | 61.65 | Sell |
| 50-day SMA: | 55.97 | Buy |
| 200-day SMA: | 37.84 | Buy |
| 8-day EMA: | 58.76 | Sell |
| 20-day EMA: | 59.68 | Sell |
| 50-day EMA: | 56.33 | Buy |
| 200-day EMA: | 41.98 | Buy |
DoubleLine Yield Opportunities Fund Earnings Growth & DLY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
AnaptysBio, Inc. Earnings Growth & ANAB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.65 per share, a decrease next quarter of $0.13 per share, a decrease this year of $2.63 per share, and an increase next year of $0.54 per share.
DoubleLine Yield Opportunities Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
AnaptysBio, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||